Visceral fat in hypertension: influence on insulin resistance and beta-cell function
- PMID: 15262911
- DOI: 10.1161/01.HYP.0000137982.10191.0a
Visceral fat in hypertension: influence on insulin resistance and beta-cell function
Erratum in
- Hypertension. 2004 Nov;44(5):e8. Postano, Vincenzo [corrected to Positano, Vincenzo]
Abstract
Preferential visceral adipose tissue (VAT) deposition has been associated with the presence of insulin resistance in obese and diabetic subjects. The independent association of VAT accumulation with hypertension and its impact on insulin sensitivity and beta-cell function have not been assessed. We measured VAT and subcutaneous fat depots by multiscan MRI in 13 nondiabetic men with newly detected, untreated essential hypertension (blood pressure=151+/-2/94+/-2 mm Hg, age=47+/-2 years, body mass index [BMI]=28.4+/-0.7 kg x m(-2)) and 26 age-matched and BMI-matched normotensive men (blood pressure=123+/-1/69+/-2 mm Hg). Insulin secretion was measured by deconvolution of C-peptide data obtained during an oral glucose tolerance test, and dynamic indices of beta-cell function were calculated by mathematical modeling. For a similar fat mass in the scanned abdominal region (4.8+/-0.3 versus 3.9+/-0.3 kg, hypertensive subjects versus controls, P=0.06), hypertensive subjects had 60% more VAT than controls (1.6+/-0.2 versus 1.0+/-0.1 kg, P=0.003). Intrathoracic fat also was expanded in patients versus controls (45+/-5 versus 28+/-3 cm2, P=0.005). Insulin sensitivity was reduced (10.7+/-0.7 versus 12.9+/-0.4 mL x min(-1) x kg(ffm)(-1), P=0.006), and total insulin output was proportionally increased (64 [21] versus 45 [24] nmol x m(-2). h, median [interquartile range], P=0.01), but dynamic indices of beta-cell function (glucose sensitivity, rate sensitivity, and potentiation) were similar in the 2 groups. Abdominal VAT, insulin resistance, and blood pressure were quantitatively interrelated (rho's of 0.39 to 0.47, P<0.02 or less). In newly found, untreated men with essential hypertension, fat is preferentially accumulated intraabdominally and intrathoracically. Such visceral adiposity is quantitatively related to both height of blood pressure and severity of insulin resistance, but has no impact on the dynamics of beta-cell function.
Comment in
-
Mediastinal fat, insulin resistance, and hypertension.Hypertension. 2004 Aug;44(2):117-8. doi: 10.1161/01.HYP.0000137993.70745.82. Epub 2004 Jul 12. Hypertension. 2004. PMID: 15249549 No abstract available.
Similar articles
-
Visceral fat and beta cell function in non-diabetic humans.Diabetologia. 2005 Oct;48(10):2090-6. doi: 10.1007/s00125-005-1891-3. Epub 2005 Aug 6. Diabetologia. 2005. PMID: 16086140
-
Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity.Metabolism. 1997 Feb;46(2):123-9. doi: 10.1016/s0026-0495(97)90288-2. Metabolism. 1997. PMID: 9030815
-
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.Gastroenterology. 2007 Aug;133(2):496-506. doi: 10.1053/j.gastro.2007.04.068. Epub 2007 May 1. Gastroenterology. 2007. PMID: 17681171
-
Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome.Horm Metab Res. 2002 Nov-Dec;34(11-12):616-21. doi: 10.1055/s-2002-38256. Horm Metab Res. 2002. PMID: 12660870 Review.
-
[Obesity and arterial hypertension. Relation between insulin secretion, peripheral insulin resistance and pressure indices].Clin Ter. 1995 Apr;146(4):279-87. Clin Ter. 1995. PMID: 7796560 Review. Italian.
Cited by
-
Prevalence of metabolic syndrome and its association with CT-based central adiposity measures: a cross-sectional study at a tertiary care hospital in Pakistan.BMJ Open. 2024 Jul 23;14(7):e082095. doi: 10.1136/bmjopen-2023-082095. BMJ Open. 2024. PMID: 39043597 Free PMC article.
-
The effect of insulin resistance in the association between obesity and hypertension incidence among Chinese middle-aged and older adults: data from China health and retirement longitudinal study (CHARLS).Front Public Health. 2024 Feb 13;12:1320918. doi: 10.3389/fpubh.2024.1320918. eCollection 2024. Front Public Health. 2024. PMID: 38414903 Free PMC article.
-
MANP in Hypertension With Metabolic Syndrome: Proof-of-Concept Study of Natriuretic Peptide-Based Therapy for Cardiometabolic Disease.JACC Basic Transl Sci. 2023 Nov 1;9(1):18-29. doi: 10.1016/j.jacbts.2023.08.011. eCollection 2024 Jan. JACC Basic Transl Sci. 2023. PMID: 38362338 Free PMC article.
-
Pericardial Adipose Tissue Thrombospondin-1 Associates With Antiangiogenesis in Ischemic Heart Disease.Am J Cardiol. 2024 Jan 1;210:201-207. doi: 10.1016/j.amjcard.2023.09.104. Epub 2023 Oct 18. Am J Cardiol. 2024. PMID: 37863116
-
Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk.Int J Mol Sci. 2023 Sep 27;24(19):14651. doi: 10.3390/ijms241914651. Int J Mol Sci. 2023. PMID: 37834099 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous